Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 12K | $2.79M | $232.95 | May 8, 2025 | Direct |
FRACTYL HEALTH, INC. | Director | Common Stock | 8.55K | $9.96K | $1.17 | Mar 13, 2025 | Direct |
SQZ Biotechnologies Co | Director, 10%+ Owner | Stock Option | 39.9K | Jun 14, 2023 | Direct | ||
FRACTYL HEALTH, INC. | Director | Stock Option | 22.5K | Jun 11, 2025 | Direct | ||
ALNYLAM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 1.56K | May 8, 2025 | Direct |